See also this year's filing and all EDGAR filings for this company.
PDF Report 0001851657_2022_Vaxxinity_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.00026967143815049123, 'aggregate_val': 137241000, 'exp_sum': 137204000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 1937000, 'SellingGeneralAndAdministrativeExpense': 51825000, 'ResearchAndDevelopmentExpense': 71379000, 'remainder_Expenses': 12063000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.0011953818614318151, 'aggregate_val': 166673000, 'exp_sum': 166474000, 'exp_to_value': {'AssetsCurrent': 154129000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 12173000, 'remainder_Assets': 172000}} |
Graph
Absolute values for 0001851657, Vaxxinity Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 154,129,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,173,000 |
| 3 | remainder_Assets | 371,000 |
| 4 | LiabilitiesCurrent | 27,494,000 |
| 5 | LiabilitiesNoncurrent | 237,000 |
| 6 | remainder_Liabilities | 10,323,000 |
| 7 | CostOfGoodsAndServicesSold | 1,937,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 51,825,000 |
| 9 | ResearchAndDevelopmentExpense | 71,379,000 |
| 10 | remainder_Expenses | 12,100,000 |
| 11 | remainder_Revenues | 66,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 166,673,000 |
| 1 | Liabilities | 38,054,000 |
| 2 | Expenses | 137,241,000 |
| 3 | Revenues | 66,000 |
| 4 | StockholdersEquity | 128,619,000 |
| 5 | NetIncome | -137,175,000 |
| 6 | ComprehensiveNetIncome | -137,175,000 |
| 7 | BaseVar | 171,017,000 |
| 8 | EconomicCapitalRatio | 0.821 |
Edgar->Model Mapping
Feature Distribution
Change over Time
